CD8A and neoplasm: As shown in Figure 6, compared with non-treated mice, immunosuppression-related PD-1+ CD8+ T cells were observed, with decreases of 540% and 340% in TDLNs (Figure 7a,b) and the TME (Figure 7c,d) after two vaccinations, respectively, indicating a potent anti-tumor efficacy.